Lagoda Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,000
| Closed | -$120K | – | 43 |
|
|
2017
Q4 | $120K | Sell |
1,000
-7,905
| -89% | -$949K | 0.05% | 30 |
|
|
2017
Q3 | $1.25M | Sell |
8,905
-2,200
| -20% | -$309K | 0.45% | 22 |
|
|
2017
Q2 | $1.35M | Sell |
11,105
-106,840
| -91% | -$13M | 0.52% | 21 |
|
|
2017
Q1 | $14.3M | Sell |
117,945
-43,257
| -27% | -$5.24M | 5.55% | 9 |
|
|
2016
Q4 | $19.7M | Buy |
161,202
+3,349
| +2% | +$410K | 6.77% | 7 |
|
|
2016
Q3 | $19.3M | Buy |
157,853
+293
| +0.2% | +$35.9K | 5.82% | 9 |
|
|
2016
Q2 | $18.4M | Sell |
157,560
-1,922
| -1% | -$224K | 6.86% | 8 |
|
|
2016
Q1 | $22.2M | Sell |
159,482
-5,527
| -3% | -$769K | 7.27% | 4 |
|
|
2015
Q4 | $31.5M | Sell |
165,009
-1,905
| -1% | -$363K | 8.34% | 3 |
|
|
2015
Q3 | $26.1M | Buy |
166,914
+3,528
| +2% | +$552K | 7.62% | 3 |
|
|
2015
Q2 | $29.5M | Buy |
163,386
+8,923
| +6% | +$1.61M | 7.74% | 4 |
|
|
2015
Q1 | $26.8M | Sell |
154,463
-46,002
| -23% | -$7.97M | 7.16% | 3 |
|
|
2014
Q4 | $37.1M | Buy |
+200,465
| New | +$37.1M | 9.9% | 2 |
|